NCT05308628View on ClinicalTrials.gov

Pediatric Liver Transplantation-Liver Fibrosis Evaluation by Using Fibrosis Panel

NARecruitingINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

April 30, 2022

Primary Completion Date

August 31, 2024

Study Completion Date

November 30, 2025

Conditions
Liver FibrosisPediatric DisorderLiver Transplant; Complications
Interventions
DIAGNOSTIC_TEST

Liver Allograft Fibrosis by Using Fibrosis Panel(PRO-C3, PIIINP, TIMP-1, HA etc.)

Liver biopsies will be performed at 3 months, 6 months and 12 months post-transplant. Fibrosis was evaluated using the liver allograft fibrosis score (LAFSc) staging system. Liver Allograft Fibrosis by Using Fibrosis Panel(PRO-C3, PIIINP, TIMP-1, HA)or (FBLN3,YKL40,LECT2 etc.)

Trial Locations (2)

200127

RECRUITING

Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

NOT_YET_RECRUITING

Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER